December 25, 2019
Sosei Group said on December 24 that its partner Pfizer has nominated an oral small molecule targeting a G protein-coupled receptor (GPCR) associated with metabolic and other diseases as a clinical development candidate under their drug discovery collaboration deal. Sosei...read more